There is increasing evidence that molecular mechanisms and cascades are involved in the pathology of depression such as low-level neurotrophic factors, in particular, brain-derived neurotrophic factor (BDNF) [10], chronic inflammation [11], the hypothalamic-pituitary-adrenal (HPA) axis deregulation [12], etc. [13]. This evidence concerns the gene BDNF and depressive symptom measurement.